Am. J. Respir. Cell Mol. Biol., Vol 11, No. 4, Oct 1994, 439-445.
Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro
AD Cambrey, NK Harrison, KE Dawes, AM Southcott, CM Black, RM du Bois, GJ Laurent and RJ McAnulty
Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.
Pulmonary fibrosis is a major cause of morbidity and mortality in patients
with systemic sclerosis (SSc). The pathogenesis of this condition is poorly
understood, but one of the earliest pathologic features is endothelial and
epithelial cell injury with subsequent regeneration. Endothelial and
epithelial cells can release several mediators, including endothelin-1
(ET-1). In this study, we investigated the levels of ET-1 in
bronchoalveolar lavage fluid (BALF) from patients with SSc and assessed the
contribution of ET-1 to the fibroblast mitogenic activity induced by these
fluids. A total of 26 patients were evaluated and divided into those with
evidence of pulmonary fibrosis, assessed by thin-section computed
tomography (group I, n = 16), and those with a normal scan (group II, n =
10). BALF from both groups of patients stimulated fibroblast proliferation.
Values expressed as median (range) percentage increase above media controls
were 25.5% (5.0 to 47.8%) and 27.6% (10.9 to 51.6%) for groups I and II,
respectively (P < 0.02 in both cases). Mitogenic activity was inhibited
by about 40% in the presence of either a neutralizing antibody to ET-1 or
two synthetic ET-1 receptor ligands. Levels of ET-1 in BALF, expressed as
medians (range) were 2.90 ng/mg albumin (0.68 to 5.75) in patients with SSc
and 1.23 ng/mg albumin (0.84 to 2.0) in control patients (P < 0.02).
Furthermore, ET-1 levels in BALF from patients in group II (3.83 ng/mg
albumin, range 1.76 to 5.75) were elevated compared with those in group I
(2.62 ng/mg albumin, range 0.68 to 3.81; P < 0.05).(ABSTRACT TRUNCATED
AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
R. M. du Bois
Blocking endothelin: breaking new ground
Eur. Respir. Rev.,
August 1, 2007;
16(102):
24 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jain, P. W. Shaul, Z. Borok, and B. C. Willis
Endothelin-1 Induces Alveolar Epithelial-Mesenchymal Transition through Endothelin Type A Receptor-Mediated Production of TGF-beta1
Am. J. Respir. Cell Mol. Biol.,
July 1, 2007;
37(1):
38 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H.S. Kim and L. J. Rubin
Endothelin in Health and Disease: Endothelin Receptor Antagonists in the Management of Pulmonary Artery Hypertension
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2002;
7(1):
9 - 19.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. MARSHALL, G. BELLINGAN, S. WEBB, A. PUDDICOMBE, N. GOLDSACK, R. J. MCANULTY, and G. J. LAURENT
Fibroproliferation Occurs Early in the Acute Respiratory Distress Syndrome and Impacts on Outcome
Am. J. Respir. Crit. Care Med.,
November 1, 2000;
162(5):
1783 - 1788.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Li, M. Rahmanian, C. Widström, G. Lepperdinger, G. I. Frost, and P. Heldin
Irradiation-Induced Expression of Hyaluronan (HA) Synthase 2 and Hyaluronidase 2 Genes in Rat Lung Tissue Accompanies Active Turnover of HA and Induction of Types I and III Collagen Gene Expression
Am. J. Respir. Cell Mol. Biol.,
September 1, 2000;
23(3):
411 - 418.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Teder and P. W. Noble
A Cytokine Reborn? . Endothelin-1 in Pulmonary Inflammation and Fibrosis
Am. J. Respir. Cell Mol. Biol.,
July 1, 2000;
23(1):
7 - 10.
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Hocher, A. Schwarz, K. A. Fagan, C. Thöne-Reineke, K. El-Hag, H. Kusserow, S. Elitok, C. Bauer, H.-H. Neumayer, D. M. Rodman, et al.
Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice
Am. J. Respir. Cell Mol. Biol.,
July 1, 2000;
23(1):
19 - 26.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. J. Abraham, X. Shiwen, C. M. Black, S. Sa, Y. Xu, and A. Leask
Tumor Necrosis Factor alpha Suppresses the Induction of Connective Tissue Growth Factor by Transforming Growth Factor-beta in Normal and Scleroderma Fibroblasts
J. Biol. Chem.,
May 12, 2000;
275(20):
15220 - 15225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bouthillier, R. Vincent, P. Goegan, I. Y. R. Adamson, S. Bjarnason, M. Stewart, J. Guenette, M. Potvin, and P. Kumarathasan
Acute Effects of Inhaled Urban Particles and Ozone : Lung Morphology, Macrophage Activity, and Plasma Endothelin-1
Am. J. Pathol.,
December 1, 1998;
153(6):
1873 - 1884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Mutsaers, M. L. Foster, R. C. Chambers, G. J. Laurent, and R. J. McAnulty
Increased Endothelin-1 and Its Localization during the Development of Bleomycin-induced Pulmonary Fibrosis in Rats
Am. J. Respir. Cell Mol. Biol.,
May 1, 1998;
18(5):
611 - 619.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. ODOUX, B. CRESTANI, G. LEBRUN, C. ROLLAND, P. AUBIN, N. SETA, M.-F. KAHN, J. FIET, and M. AUBIER
Endothelin-1 Secretion by Alveolar Macrophages in Systemic Sclerosis
Am. J. Respir. Crit. Care Med.,
November 1, 1997;
156(5):
1429 - 1435.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1994 American Thoracic Society.
|
|
|